The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 4, 2009, Pages 528-535

  Sanganalmath, Santosh K ^a   Stein, Adam B ^a   Guo, Yiru ^a   Tiwari, Sumit ^a   Hunt, Greg ^a   Vincent, Robert J ^a   Huang, Yiming ^a   Rezazadeh, Arash ^a   Ildstad, Suzanne T ^a   Dawn, Buddhadeb ^a   Bolli, Roberto ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Bone marrow; Cytokine; Heart failure; Myocardial repair; Stem cell; Ventricular remodeling

Indexed keywords

FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; ECHOCARDIOGRAPHY; FOLLOW UP; HEART DILATATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; LONG TERM CARE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

ANIMALS; CARDIOMEGALY; CYTOKINES; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; MYOCARDIAL INFARCTION; STEM CELL FACTOR; SYSTOLE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

MUS;

EID: 69249212271     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.07.009     Document Type: Article

References (34)

1. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10344-10349
2. Dawn B., Guo Y., Rezazadeh A., Huang Y., Stein A.B., Hunt G., et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ. Res. 98 (2006) 1098-1105
3. Moon C., Krawczyk M., Ahn D., Ahmet I., Paik D., Lakatta E.G., et al. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11612-11617
4. Zou Y., Takano H., Mizukami M., Akazawa H., Qin Y., Toko H., et al. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 108 (2003) 748-753
5. Fukuhara S., Tomita S., Nakatani T., Ohtsu Y., Ishida M., Yutani C., et al. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell. Transplant. 13 (2004) 741-748
6. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori V.M., Perin E.C., Hornung C.A., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 167 (2007) 989-997
7. Dai W., Hale S.L., Martin B.J., Kuang J.Q., Dow J.S., Wold L.E., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112 (2005) 214-223
8. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
9. Valgimigli M., Rigolin G.M., Cittanti C., Malagutti P., Curello S., Percoco G., et al. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur. Heart J. 26 (2005) 1838-1845
10. Ellis S.G., Penn M.S., Bolwell B., Garcia M., Chacko M., Wang T., et al. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: results of a pilot dose-escalation randomized trial. Am. Heart J. 152 1051 (2006) e9-14
11. Engelmann M.G., Theiss H.D., Hennig-Theiss C., Huber A., Wintersperger B.J., Werle-Ruedinger A.E., et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J. Am. Coll. Cardiol. 48 (2006) 1712-1721
12. Ripa R.S., Jorgensen E., Wang Y., Thune J.J., Nilsson J.C., Sondergaard L., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
13. Zohlnhofer D., Ott I., Mehilli J., Schomig K., Michalk F., Ibrahim T., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295 (2006) 1003-1010
14. Leone A.M., Galiuto L., Garramone B., Rutella S., Giannico M.B., Brugaletta S., et al. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the Rigenera study). Am. J. Cardiol. 100 (2007) 397-403
15. Zohlnhofer D., Dibra A., Koppara T., de Waha A., Ripa R.S., Kastrup J., et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis. J. Am. Coll. Cardiol. 51 (2008) 1429-1437
16. Abdel-Latif A., Bolli R., Zuba-Surma E.K., Tleyjeh I.M., Hornung C.A., and Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am. Heart J. 156 (2008) 216-226 e9
17. Guo Y., Wu W.J., Qiu Y., Tang X.L., Yang Z., and Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am. J. Physiol. 275 (1998) H1375-H1387
18. Dawn B., Tiwari S., Kucia M.J., Zuba-Surma E.K., Guo Y., Sanganalmath S.K., et al. Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction. Stem Cells 26 (2008) 1646-1655
19. Tanaka H., Satake-Ishikawa R., Ishikawa M., Matsuki S., and Asano K. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats. Cancer Res. 51 (1991) 3710-3714
20. Rotondaro L., De Paolis E., Ferrero D., D'Alatri L., Raucci G., Fabbri A., et al. Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice. Mol. Biotechnol. 11 (1999) 117-128
21. Lynch D.H., Jacobs C., DuPont D., Eisenman J., Foxworthe D., Martin U., et al. Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF). Lymphokine Cytokine Res. 11 (1992) 233-243
22. Li Q., Li B., Wang X., Leri A., Jana K.P., Liu Y., et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100 (1997) 1991-1999
23. Wallenstein S., Zucker C.L., and Fleiss J.L. Some statistical methods useful in circulation research. Circ. Res. 47 (1980) 1-9
24. Ohtsuka M., Takano H., Zou Y., Toko H., Akazawa H., Qin Y., et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J. 18 (2004) 851-853
25. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11 (2005) 305-311
26. Kanellakis P., Slater N.J., Du X.J., Bobik A., and Curtis D.J. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. Cardiovasc. Res. 70 (2006) 117-125
27. Sudo Y., Shimazaki C., Ashihara E., Kikuta T., Hirai H., Sumikuma T., et al. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice. Blood 89 (1997) 3186-3191
28. Kronenwett R., Martin S., and Haas R. The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells. Stem Cells 18 (2000) 320-330
29. Misao Y., Takemura G., Arai M., Ohno T., Onogi H., Takahashi T., et al. Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc. Res. 71 (2006) 455-465
30. Kucia M., Dawn B., Hunt G., Guo Y., Wysoczynski M., Majka M., et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ. Res. 95 (2004) 1191-1199
31. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Sustained 2 year clinical benefit from intracoronary infusion of bone marrow-derived progenitor cells in patients after acute myocardial infarction. Circulation 116 (2007) II_777 (abstract)
32. Molineux G., McCrea C., Yan X.Q., Kerzic P., and McNiece I. Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood 89 (1997) 3998-4004
33. Neipp M., Zorina T., Domenick M.A., Exner B.G., and Ildstad S.T. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential. Blood 92 (1998) 3177-3188
34. Lyman S.D. Biology of flt3 ligand and receptor. Int. J. Hematol. 62 (1995) 63-73